Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 29/100

Termination Rate

9.1%

1 terminated out of 11 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

45%

5 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results83% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (5)
P 3 (2)
P 4 (3)

Trial Status

Completed5
Recruiting3
Unknown2
Terminated1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (11)

Research Network

Activity Timeline